BR9916515A - Polinucleotìdeo, vetor de expressão, células de e. coli e de agrobacterium tumefaciens transformadas com o vetor de expressão, célula de planta transgênica, semente de planta transgênica, célula eucariótica transgênica, composição imunogênica, método de evocar uma resposta imune em um animal ou ser humano, planta transgênica, e, adjuvante - Google Patents
Polinucleotìdeo, vetor de expressão, células de e. coli e de agrobacterium tumefaciens transformadas com o vetor de expressão, célula de planta transgênica, semente de planta transgênica, célula eucariótica transgênica, composição imunogênica, método de evocar uma resposta imune em um animal ou ser humano, planta transgênica, e, adjuvanteInfo
- Publication number
- BR9916515A BR9916515A BR9916515-5A BR9916515A BR9916515A BR 9916515 A BR9916515 A BR 9916515A BR 9916515 A BR9916515 A BR 9916515A BR 9916515 A BR9916515 A BR 9916515A
- Authority
- BR
- Brazil
- Prior art keywords
- transgenic plant
- expression vector
- transgenic
- coli
- adjuvant
- Prior art date
Links
- 230000009261 transgenic effect Effects 0.000 title abstract 7
- 239000013604 expression vector Substances 0.000 title abstract 4
- 239000002671 adjuvant Substances 0.000 title abstract 3
- 102000040430 polynucleotide Human genes 0.000 title abstract 2
- 108091033319 polynucleotide Proteins 0.000 title abstract 2
- 239000002157 polynucleotide Substances 0.000 title abstract 2
- 210000004027 cell Anatomy 0.000 title 2
- 241000589155 Agrobacterium tumefaciens Species 0.000 title 1
- 210000003527 eukaryotic cell Anatomy 0.000 title 1
- 230000000763 evoking effect Effects 0.000 title 1
- 230000028993 immune response Effects 0.000 title 1
- 230000002163 immunogen Effects 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 241000588724 Escherichia coli Species 0.000 abstract 2
- 241000607626 Vibrio cholerae Species 0.000 abstract 2
- 241000589158 Agrobacterium Species 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003053 toxin Substances 0.000 abstract 1
- 231100000765 toxin Toxicity 0.000 abstract 1
- 229940118696 vibrio cholerae Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
"POLINUCLEOTìDEO,VETOR DE EXPRESSãO, CéLULAS DE COLI E DE AGROBACTERIUM TUMEFACIENS TRANSFORMADAS COM O VETOR DE EXPRESSãO, CéLULA DE PLANTA TRANSGêNICA, SEMENTE DE PLANTA TRANSGêNICA CéLULA EUCARIóTICA TRANSGêNICA, COMPOSIçãO IMUNOGêNICA, MéTODO DE EVOCAR UMA RESPOSTA IMUNE EM UM ANIMAL OU SER HUMANO, PLANTA TRANSGêNICA, E, ADJUVANTE". A invenção fornece polipeptídeos mutantes de Escherichia coli instáveis ao calor (LT) e da toxina Vibrio cholerae (CT) e os polinucleotídeos que os codificam. Os polipeptídeos mutantes LT e CT podem ser facilmente produzidos em plantas e podem ser usados para tratar ou impedir doenças causadas pelo E. coli e pelo V. cholera. Os polipeptídeos também são utilizáveis como adjuvantes.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11350798P | 1998-12-22 | 1998-12-22 | |
PCT/US1999/030747 WO2000037609A2 (en) | 1998-12-22 | 1999-12-22 | Orally immunogenic bacterial enterotoxins expressed in transgenic plants |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9916515A true BR9916515A (pt) | 2001-11-06 |
Family
ID=22349850
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9916515-5A BR9916515A (pt) | 1998-12-22 | 1999-12-22 | Polinucleotìdeo, vetor de expressão, células de e. coli e de agrobacterium tumefaciens transformadas com o vetor de expressão, célula de planta transgênica, semente de planta transgênica, célula eucariótica transgênica, composição imunogênica, método de evocar uma resposta imune em um animal ou ser humano, planta transgênica, e, adjuvante |
Country Status (9)
Country | Link |
---|---|
US (1) | US20030176653A1 (pt) |
EP (1) | EP1175144A4 (pt) |
JP (1) | JP2002533068A (pt) |
CN (1) | CN1191357C (pt) |
AU (1) | AU773953B2 (pt) |
BR (1) | BR9916515A (pt) |
CA (1) | CA2359586A1 (pt) |
MX (1) | MXPA01006294A (pt) |
WO (1) | WO2000037609A2 (pt) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9513371D0 (en) * | 1995-06-30 | 1995-09-06 | Biocine Spa | Immunogenic detoxified mutant toxins |
GB9326174D0 (en) * | 1993-12-22 | 1994-02-23 | Biocine Sclavo | Mucosal adjuvant |
CN100410268C (zh) * | 1998-12-23 | 2008-08-13 | 博伊斯汤普生植物研究所 | 免疫原性的乙型肝炎表面抗原在转基因植物中的表达 |
DE60234695D1 (de) * | 2001-06-07 | 2010-01-21 | Univ Colorado | Mutantenformen von cholera holotoxin als adjuvans |
CA2449670A1 (en) * | 2001-06-07 | 2002-12-12 | Wyeth Holdings Corporation | Mutant forms of cholera holotoxin as an adjuvant |
JP2004535192A (ja) * | 2001-06-08 | 2004-11-25 | イコン ジェネティクス インコーポレイティッド | 植物中におけるタンパク質の産生 |
US7109397B2 (en) * | 2002-02-12 | 2006-09-19 | Cornell Research Foundation, Inc. | Pseudomonas syringae harpins, HopPtoP and HopPmaHPto, and their uses |
US20040146533A1 (en) * | 2002-08-27 | 2004-07-29 | Miller Timothy J. | Use of escherichia coli heat labile toxin as an adjuvant in birds and poultry |
DK1767639T3 (da) * | 2004-05-31 | 2012-06-11 | Kitasato Daiichi Sankyo Vaccine Co Ltd | Orale anti-leucocytozoonose-vacciner på basis af transgeniske planter |
US20090304733A1 (en) * | 2004-07-28 | 2009-12-10 | Jacob Pitcovski | Vaccine comprising recombinant ct or lt toxin |
CN100387719C (zh) * | 2005-05-09 | 2008-05-14 | 中国农业科学院生物技术研究所 | 编码大肠杆菌热敏毒素基因及其表达载体和用途 |
CN1324138C (zh) * | 2005-07-21 | 2007-07-04 | 华东理工大学 | 大肠杆菌热敏毒素b亚单位的真核表达方法 |
AU2006312126A1 (en) | 2005-11-04 | 2007-05-18 | Dow Agrosciences Llc | Preparation of vaccine master cell lines using recombinant plant suspension cultures |
CN100500842C (zh) * | 2006-03-09 | 2009-06-17 | 昆明理工大学 | 一种大肠杆菌热不稳定肠毒素的制备方法 |
US20080028487A1 (en) * | 2006-06-06 | 2008-01-31 | The University Of Nebraska-Lincoln | USES OF THE PSEUDOMONAS SYRINGAE EFFECTOR PROTEIN HopU1 RELATED TO ITS ABILITY TO ADP-RIBOSYLATE EUKARYOTIC RNA BINDING PROTEINS |
EP2287300B1 (en) | 2008-05-02 | 2018-06-27 | Idemitsu Kosan Co., Ltd. | Bacterial toxin vaccine |
KR101233018B1 (ko) | 2010-02-05 | 2013-02-13 | 전북대학교산학협력단 | 대장균 장독소 b 서브유닛 유전자로 형질전환된 식물배양체, 및 이를 포함하는 백신 |
TWI451874B (zh) * | 2010-05-03 | 2014-09-11 | Dev Center Biotechnology | 多醣體與大腸桿菌熱不穩定腸毒素之共軛物,其用途及製法 |
WO2013191225A1 (ja) | 2012-06-20 | 2013-12-27 | 国立大学法人 東京大学 | 粘膜免疫賦活化剤及びhpv感染症治療用経口医薬組成物 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL101715A (en) * | 1991-05-02 | 2005-06-19 | Amgen Inc | Recombinant dna-derived cholera toxin subunit analogs |
GB9513371D0 (en) * | 1995-06-30 | 1995-09-06 | Biocine Spa | Immunogenic detoxified mutant toxins |
IT1253009B (it) * | 1991-12-31 | 1995-07-10 | Sclavo Ricerca S R L | Mutanti immunogenici detossificati della tossina colerica e della tossina lt, loro preparazione ed uso per la preparazione di vaccini |
JPH10507916A (ja) * | 1994-10-24 | 1998-08-04 | ザ テキサス エーアンドエム ユニバーシティ システム | トランスジェニック植物による経口免疫 |
GB9622660D0 (en) * | 1996-10-31 | 1997-01-08 | Biocine Spa | Immunogenic detoxified mutant toxin |
US5980898A (en) * | 1996-11-14 | 1999-11-09 | The United States Of America As Represented By The U.S. Army Medical Research & Material Command | Adjuvant for transcutaneous immunization |
US6818222B1 (en) * | 1997-03-21 | 2004-11-16 | Chiron Corporation | Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants |
FI110323B (fi) * | 1997-06-02 | 2002-12-31 | Timo Korpela | Rekombinanttikonstrukti geenin ilmentämisen lisäämiseksi kasveissa |
-
1999
- 1999-12-22 WO PCT/US1999/030747 patent/WO2000037609A2/en active IP Right Grant
- 1999-12-22 MX MXPA01006294A patent/MXPA01006294A/es not_active IP Right Cessation
- 1999-12-22 CN CNB998149632A patent/CN1191357C/zh not_active Expired - Fee Related
- 1999-12-22 AU AU23818/00A patent/AU773953B2/en not_active Ceased
- 1999-12-22 EP EP99967556A patent/EP1175144A4/en not_active Withdrawn
- 1999-12-22 JP JP2000589665A patent/JP2002533068A/ja active Pending
- 1999-12-22 BR BR9916515-5A patent/BR9916515A/pt not_active Application Discontinuation
- 1999-12-22 CA CA002359586A patent/CA2359586A1/en not_active Abandoned
-
2002
- 2002-12-30 US US10/334,729 patent/US20030176653A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU773953B2 (en) | 2004-06-10 |
EP1175144A4 (en) | 2002-10-30 |
WO2000037609A3 (en) | 2000-09-14 |
MXPA01006294A (es) | 2002-06-04 |
WO2000037609A2 (en) | 2000-06-29 |
CN1191357C (zh) | 2005-03-02 |
EP1175144A2 (en) | 2002-01-30 |
CA2359586A1 (en) | 2000-06-29 |
JP2002533068A (ja) | 2002-10-08 |
CN1331558A (zh) | 2002-01-16 |
US20030176653A1 (en) | 2003-09-18 |
AU2381800A (en) | 2000-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9916515A (pt) | Polinucleotìdeo, vetor de expressão, células de e. coli e de agrobacterium tumefaciens transformadas com o vetor de expressão, célula de planta transgênica, semente de planta transgênica, célula eucariótica transgênica, composição imunogênica, método de evocar uma resposta imune em um animal ou ser humano, planta transgênica, e, adjuvante | |
Batschauer | A plant gene for photolyase: an enzyme catalyzing the repair of UV‐light‐induced DNA damage | |
MY108154A (en) | Immunogenic detoxified mutants, of cholera toxin and of the toxin lt, their preparation and their use for the preparation of vaccines. | |
BR0208203A (pt) | Polipeptìdeo do fator vii, derivado do fator vii, composição, composição farmacêutica, construção de polinucleotìdeo, célula hospedeira eucariótica, animal transgênico, planta transgênica, e, métodos para produzir o polipeptìdeo do fator vii e um derivado do fator vii, uso de um derivado do fator vii, métodos para o tratamento de episódios de hemorragia ou distúrbios de hemorragia em um paciente ou para a intensificação do sistema hemostático normal e para inibir a formação de trobo em um paciente | |
Reichman et al. | Human leukocyte interferon and the antiviral factor (AVF) from virus-infected plants stimulate plant tissues to produce nucleotides with antiviral activity | |
Alderton et al. | Heat adaptation and ion exchange in Bacillus megaterium spores | |
DE3873672D1 (de) | Stilbensynthase-gen. | |
BR9508633A (pt) | Composição preparação de vacina estojo e processos para criar ou sustentar uma resposta imune protetora ou adaptadora a um antígeno em um hospedeiro e para induzir uma resposta imune protetora contra um organismo bacteriano enterotóxico | |
FI820467L (fi) | Farmaceutiska kompositioner som frigoers kontinuerligt | |
ES2147551T3 (es) | Procedimiento para transformar plantas monocotiledoneas. | |
DK1029023T3 (da) | Brandhæmmende og biocidt præparat og fremgangsmåde til fremstilling deraf | |
DE69636735D1 (de) | Immunogene, ungiftige choleratoxinmutante | |
ES2164636T3 (es) | Plasmidos para la produccion de plantas transgenicas que se modifican en su constitucion fisica y rendimiento. | |
ES2196293T3 (es) | Procedimiento e instalacion para la inactivacion enzimatica subsiguiente a la extraccion de pure de productos alimenticios. | |
BR9808430A (pt) | Método para melhorar a especificidade da regulação de gens em um organismo transformado | |
ES8206447A1 (es) | Procedimiento para preparar derivados de enterotoxina termoestable (st) de e. coli. | |
Karpova et al. | Lectins of Sambucus nigra as biologically active and DNA-protective substances | |
AR036178A1 (es) | Genes de la desaturasa del acido graso de la granada y procedimiento para la preparacion de acidos grasos insaturados | |
PT824548E (pt) | Moleculas hibridas entre a enterotoxina labil ao calor e a subunidade b da toxina da colera | |
MX9206806A (es) | Pudines listos para tomar que contienen polifosfato | |
NZ332973A (en) | 1-Galactose derivatives which inhibit binding of toxins such as heat labile enterotoxin or cholera toxin | |
Welsh et al. | Heat-shock treatment of mouse pancreatic islets results in a partial loss of islet cells but no remaining functional impairment among the surviving β cells | |
AR002648A1 (es) | Procedimiento para preparar un producto de carne en trozos. | |
CO4870727A1 (es) | Inhibicion pre y post cosecha de la transformacion de pro- ductos almacenados | |
NO952601L (no) | Oligonukleotider for inhibering av ekspresjon av isoprenylprotein-transferaser |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8, 13 E 37 DA LPI |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |